Associated Genetic Biomarkers
NCI Definition: The most common odontogenic tumor, arising from the epithelial component of the embryonic tooth and usually affecting the molar-ramus region of the mandible or maxilla. Although most ameloblastomas are morphologically and clinically benign, they may cause extensive local destruction, recur, or metastasize. 
There is 1 clinical trial for ameloblastoma, of which 1 is open and 0 are completed or closed. Of the trial that contains ameloblastoma as an inclusion criterion, 1 is phase 2 (1 open).
BRAF is the most frequent gene inclusion criterion for ameloblastoma clinical trials .
Significant Genes in Ameloblastoma
BRAF is an inclusion eligibility criterion in 1 clinical trial for ameloblastoma, of which 1 is open and 0 are closed. Of the trial that contains BRAF status and ameloblastoma as inclusion criteria, 1 is phase 2 (1 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.